176 related articles for article (PubMed ID: 32616496)
21. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
[TBL] [Abstract][Full Text] [Related]
22. Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images.
Testa F; Fontana F; Pollastri F; Chester J; Leonelli M; Giaroni F; Gualtieri F; Bolelli F; Mancini E; Nordio M; Sacco P; Ligabue G; Giovanella S; Ferri M; Alfano G; Gesualdo L; Cimino S; Donati G; Grana C; Magistroni R
Clin J Am Soc Nephrol; 2022 Sep; 17(9):1316-1324. PubMed ID: 35882505
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function.
Tan M; Fang J; Xu Q; Zhang C; Zou G; Wang M; Li W
Ren Fail; 2019 Nov; 41(1):875-882. PubMed ID: 31517550
[No Abstract] [Full Text] [Related]
24. Updating the International IgA Nephropathy Prediction Tool for use in children.
Barbour SJ; Coppo R; Er L; Russo ML; Liu ZH; Ding J; Katafuchi R; Yoshikawa N; Xu H; Kagami S; Yuzawa Y; Emma F; Cambier A; Peruzzi L; Wyatt RJ; Cattran DC;
Kidney Int; 2021 Jun; 99(6):1439-1450. PubMed ID: 33220356
[TBL] [Abstract][Full Text] [Related]
25. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z
Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086
[TBL] [Abstract][Full Text] [Related]
26. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
27. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
28. Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy.
Papasotiriou M; Stangou M; Chlorogiannis D; Marinaki S; Xydakis D; Sampani E; Lioulios G; Kapsia E; Zerbala S; Koukoulaki M; Moustakas G; Fokas S; Dounousi E; Duni A; Papadaki A; Damianakis N; Bacharaki D; Stylianou K; Gakiopoulou H; Liapis G; Sakellaropoulos G; Papachristou E; Boletis I; Papagianni A; Goumenos DS
Front Med (Lausanne); 2022; 9():778464. PubMed ID: 35242773
[TBL] [Abstract][Full Text] [Related]
29. The MEST score provides earlier risk prediction in lgA nephropathy.
Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
[TBL] [Abstract][Full Text] [Related]
30. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
[TBL] [Abstract][Full Text] [Related]
31. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ
Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230
[TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
[TBL] [Abstract][Full Text] [Related]
33. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
34. Glomerular IgG deposition predicts renal outcome in patients with IgA nephropathy.
Shin DH; Lim BJ; Han IM; Han SG; Kwon YE; Park KS; Lee MJ; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
Mod Pathol; 2016 Jul; 29(7):743-52. PubMed ID: 27102346
[TBL] [Abstract][Full Text] [Related]
35. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.
Tanaka S; Ninomiya T; Masutani K; Nagata M; Tsuchimoto A; Tsuruya K; Kitazono T
Clin Exp Nephrol; 2015 Dec; 19(6):1062-70. PubMed ID: 25700934
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
[TBL] [Abstract][Full Text] [Related]
38. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY
Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247
[TBL] [Abstract][Full Text] [Related]
39. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K
PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841
[TBL] [Abstract][Full Text] [Related]
40. Clinical implication of crescentic lesions in immunoglobulin A nephropathy.
Lee MJ; Kim SJ; Oh HJ; Ko KI; Koo HM; Kim CH; Doh FM; Yoo TH; Kang SW; Choi KH; Lim BJ; Jeong HJ; Han SH
Nephrol Dial Transplant; 2014 Feb; 29(2):356-64. PubMed ID: 24081867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]